Skip links

Paidion CEO Participates in Study Published in Lancet

Preclinical data suggest that the loop-diuretic bumetanide might be an effective treatment for neonatal seizures. The study aimed to assess dose and feasibility of intravenous bumetanide as an add-on to phenobarbital for treatment of neonatal seizures. Dr. Mangum co-authored this study which was published in the May 2015 issue of Lancet Neurology. [Vol. 14 | Number 5 | May 2015]

Click Here to Read the Article:

To view the full article simply login to your Lancet account or register for free by providing a username and password – it takes no more than two minutes to register.